Azilect (Aphena Pharma Solutions – Tennessee, LLC)


Welcome to the PulseAid listing for the Azilect drug offered from Aphena Pharma Solutions – Tennessee, LLC. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aphena Pharma Solutions – Tennessee, LLC
NON-PROPRIETARY NAME: Rasagiline Mesylate
SUBSTANCE NAME: RASAGILINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-07-10
END MARKETING DATE: 0000-00-00


Azilect HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAzilect from Aphena Pharma Solutions – Tennessee, LLC
LABELER NAME: Aphena Pharma Solutions – Tennessee, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2006-07-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43353-015_7a05b579-97d9-4b52-8998-b95a634e674e
PRODUCT NDC: 43353-015
APPLICATION NUMBER: NDA021641

Other RASAGILINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Rasagiline Mesylate
Aphena Pharma Solutions – Tennessee, LLCAzilect
Ascend Laboratories, LLCRasagiline
Mylan Pharmaceuticals Inc.Rasagiline Mesylate
Physicians Total Care, Inc.Azilect
Teva Neuroscience, Inc.Azilect
Teva Pharmaceuticals USA, Inc.Rasagiline